Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells

Molecular Cancer Research

Volumn 9, Issue 8, 2011, Pages 1139-1151

  Javierre, Biola M ^a   Rodriguez Ubreva, Javier ^a   Al Shahrour, Fatima ^b,c   Corominas, Marina ^a   Graña, Osvaldo ^d   Ciudad, Laura ^a   Agirre, Xabier ^e   Pisano, David G ^d   Valencia, Alfonso ^d   Roman Gomez, Jose ^f   Calasanz, Maria Jose ^g   Prosper, Felipe ^e   Esteller, Manel ^a   Gonzalez Sarmiento, Rogelio ^h   Ballestar, Esteban ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f Reina Sofia Hospital   (Argentina)

^g UNIVERSITY OF NAVARRA   (Spain)

^h UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENE SILENCING; GENETIC DISORDER; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG RANGE EPIGENETIC SILENCING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING;

ADENOCARCINOMA; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HCT116 CELLS; HUMANS; IKAROS TRANSCRIPTION FACTOR; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC;

EID: 80051956685     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0515     Document Type: Article

References (28)

1. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007;128:683-692 (Pubitemid 46273572)
2. Costello JF, Fr¨uhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-138
3. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229 (Pubitemid 32695003)
4. Keshet I., Schlesinger Y., Farkash S., Rand E., Hecht M., Segal E., et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 2006;38:149-153 (Pubitemid 43177227)
5. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007;39:232-236 (Pubitemid 46184355)
6. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., et al. Epigenetic stem cell signature in cancer. Nat Genet 2007;39:157-158 (Pubitemid 46184343)
7. Frigola J., Song J., Stirzaker C., Hinshelwood R.A., Peinado M.A., Clark S.J., et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006;38:540-549
8. Dallosso A.R., Hancock A.L., Szemes M., Moorwood K., Chilukamarri L., Tsai H.H., et al. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS Genet 2009;5:e1000745.
9. Hsu P.Y., Hsu H.K., Singer G.A., Yan P.S., Rodriguez B.A., Liu J.C., et al. Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res 2010;20:733-744
10. Coolen M.W., Stirzaker C., Song J.Z., Statham A.L., Kassir Z., Moreno C.S., et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010;12:235-246
11. Mayor R., Casadomé L., Azuara D., Moreno V., Clark S.J., Capellà G., et al. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer 2009;100:1534-1539
12. Cortes M., Wong E., Koipally J., Georgopoulos K. Control of lymphocyte development by the Ikaros gene family. Curr Opin Immunol 1999;11:167-171 (Pubitemid 29154901)
13. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007;446:758-764 (Pubitemid 46582031)
14. Mullighan C.G., Miller C.B., Radtke I., Phillips L.A., Dalton J., Ma J., et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008;453:110-114 (Pubitemid 351630327)
15. Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., et al. Deletion of Ikaros and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-480
16. Herman J.G., Graff J.R., Myöhänen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-9826 (Pubitemid 26296693)
17. O'Geen H., Nicolet C.M., Blahnik K., Green R., Farnham P.J. Comparison of sample preparation methods for ChIP-chip assays. Biotechniques 2006;41:577-580 (Pubitemid 46534868)
18. Clark S. Action at a distance: Epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007;16:R88-R95 (Pubitemid 47241847)
19. Monk D., Arnaud P., Frost J., Hills F.A., Stanier P., Feil R., et al. Reciprocal imprinting of human GRB10 in placental trophoblast and brain: Evolutionary conservation of reversed allelic expression. Hum Mol Genet 2009;18:3066-3074
20. Bell A.C., Fesenfeld G. Methylation of a CTCF-dependent boundary controls imprinted region of the Igf2 gene. Nature 2000;405:482-485 (Pubitemid 30367427)
21. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-837 (Pubitemid 46802390)
22. Kathrein K.L., Chari S., Winandy S. Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: Implications for CD4 regulation. J Biol Chem 2008;283:10476-10484
23. Yap W.H., Yeoh E., Tay A., Brenner S., Venkatesh B. STAT4 is a target of the hematopoietic zinc-finger transcription factor Ikaros in T cells. FEBS Lett 2005;579:4470-4478 (Pubitemid 41116384)
24. Trinh L.A., Ferrini R., Cobb B.S., Weinmann A.S., Hahm K., Ernst P., et al. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 2001;15:1817-1832 (Pubitemid 32905639)
25. Wu C., Sun M., Liu L., Zhou G.W. The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 2003;306:1-12. (Pubitemid 36351390)
26. Nakamura T., Jenkins N.A., Copeland N.G. Identification of a new family of Pbx-related homeobox genes. Oncogene 1996;13:2235-2242 (Pubitemid 26411574)
27. Peng D.F., Razvi M., Chen H., Washington K., Roessner A., Schneider-Stock R., et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 2009;58:5-15.
28. Koipally J., Renold A., Kim J., Georgopoulos K. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J 1999;18:3090-3100 (Pubitemid 29255617)